Katrin Nerger

TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo

Lutz Peter Mueller, Jana Luetzkendorf, Miriam Widder et al. · Cancer Gene Therapy · 2010 · 97 citations

Regenerative Medicine, Cell Therapy, Medicine +9

Cryopreservation does not alter main characteristics of Good Manufacturing Process–grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation

Jana Luetzkendorf, Katrin Nerger, Julian Hering et al. · Cytotherapy · 2015 · 88 citations

Regenerative Medicine, Tissue Engineering, Main Characteristics +11

Growth inhibition of colorectal carcinoma by lentiviral <i>TRAIL</i>‐transgenic human mesenchymal stem cells requires their substantial intratumoral presence

Jana Luetzkendorf, Lutz Peter Mueller, Thomas Mueller et al. · Journal of Cellular and Molecular Medicine · 2009 · 72 citations · Full text

Apoptosis, Cell Death, Cell Proliferation +19

Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells

Thomas Mueller, Jana Luetzkendorf, Katrin Nerger et al. · Cellular and Molecular Life Sciences · 2008 · 47 citations · Full text

Developmental Biology, Extended Panel, Medicine +10

Resistance for Genotoxic Damage in Mesenchymal Stromal Cells Is Increased by Hypoxia but Not Generally Dependent on p53-Regulated Cell Cycle Arrest

Jana Lützkendorf, Élisabeth Wieduwild, Katrin Nerger et al. · PLoS ONE · 2017 · 15 citations · Full text

Cell Death, Oxidative Stress, Genotoxic Damage +18